Additional Information

Field Value
Baseline Year 2025
Cover Image File <FileStorage: '' ('application/octet-stream')>
Data Source Rwanda Biomedical Center TB Case Management Database, Electronic TB Register, Laboratory Information Systems, TB Treatment Cards, Contact Investigation Forms, TPT Registers
Dimensions - Geographic level (National, District, Health Facility) - Administrative units (30 Districts, Health Facilities) - Patient demographics (Age groups, Gender, Risk populations) - TB classification (Pulmonary, Extra-pulmonary, Drug-sensitive, Drug-resistant) - HIV status (HIV-positive, HIV-negative, Unknown status) - Treatment categories (New cases, Previously treated, Retreatment) - Laboratory methods (GeneXpert, Smear microscopy, Culture, DST) - Treatment outcomes (Successful, Unsuccessful, Not evaluated) - Contact investigation (Household contacts, <5 years, ≥5 years contacts) - Preventive treatment (TPT eligibility, uptake, completion)
Indicator Code RW-SCI-TB-COMP-001
Indicator Unit Number of TB cases with complete case management data
Methodology Data collected through comprehensive TB case management system with individual patient tracking: TB CASE REGISTRATION AND CLASSIFICATION: - Individual patient registration at time of TB diagnosis - Standardized case definitions aligned with WHO TB guidelines - Comprehensive demographic and clinical data collection - Risk group identification and high-risk population categorization - Geographic location tracking from community to health facility level TB DIAGNOSIS AND LABORATORY MONITORING: - Laboratory results integration (GeneXpert, microscopy, culture) - Drug susceptibility testing for rifampicin and other anti-TB drugs - WHO categorization and treatment regimen assignment - Baseline clinical assessments and nutritional status evaluation - HIV testing and co-infection management protocols TREATMENT MONITORING AND ADHERENCE: - Monthly treatment monitoring with clinical and laboratory assessments - Interim outcome evaluation at months 2, 5, and treatment completion - Side effect monitoring and adverse event documentation - Treatment supporter assignment and community health worker involvement - Weight monitoring and nutritional support provision HIV-TB CO-INFECTION MANAGEMENT: - Universal HIV testing for all TB patients - ART initiation and monitoring for HIV-positive TB patients - Cotrimoxazole preventive therapy coverage - Collaborative TB-HIV service delivery monitoring - Integrated care coordination and treatment outcomes CONTACT INVESTIGATION AND TPT: - Systematic household contact investigation for all TB patients - Contact screening for TB symptoms and disease - Tuberculosis preventive treatment (TPT) eligibility assessment - TPT initiation, monitoring, and completion tracking - Contact investigation outcomes and yield calculation TREATMENT OUTCOMES AND EVALUATION: - Standardized WHO treatment outcome definitions - Real-time treatment outcome monitoring and reporting - MDR-TB interim and final outcome assessment - Program performance indicator calculation - Cohort analysis and treatment success rate evaluation QUALITY ASSURANCE: - Real-time data validation and consistency checks - Monthly data quality assessments and cleaning - Cross-validation between laboratory and clinical databases - Annual external data verification and audit - Continuous capacity building for data collection staff
Reporting Org Rwanda Biomedical Center
Value Type value